ALSO NOTED: Solvay submits Synordia to EMEA; U.S. Senate votes in favor of stem cell funding; and much more...

> Solvay has submitted its diabetes drug Synordia to the EMEA. The treatment combines a lipid-lowering drug with an oral antidiabetic in one pill. Release

> Canada-based biotech Warnex is acquiring MDS Pharma Services pharmaceutics business. Financial details of the transaction were not disclosed. Report

> The U.S. Senate voted 63 to 37 in favor of a stem cell funding bill, but it faces almost certain death from a Presidential veto. Report

> Evotec and Genextra's DAC, a subsidiary of Genextra, will collaborate to identify small molecule therapeutics for cancer. Release

And Finally... Korean electronics maker Samsung has developed a device that can tell exactly how much fat a person has on his or her body. Article